Biochemical Basis of Some Muscle Disorder Flashcards
Duchenne
1/3500 males 30% due to new mutations Most severe is MDs Frameshift mutation Absent Dystrophin Rapid progression, wheelchair age 10, death in teens Positive Gower's sign CK Markedly elevated 50-100 times normal
Becker Muscular Dystrophy
1/20,000 males <2% new mutation Less severe with slower progression than DMD, later onset Reduced dystrophin levels or modified Point mutation CK mildly elevated
DM1 Myotonic Muscular Dystrophy
98% expansion of CTG repeats in non-coding region of DMPK gene
Chromosome 19
Shows anticipation
Generally suffer only from cataracts and mild myotonia
Congenital DM1 is particularly severe
50% patients suffer from mental retardation
DM2 Myotonic Muscular Dystrophy
Expansion of CCTG repeat in non-coding region of CNBP (ZNF9, zinc finger) gene
Chromosome 3
Myotonic Muscular Dystrophy MMD or DM
most common form of muscular dystrophy affecting adults (most with DMD die young)
1/8,000
Multisystem disorder affects heart, smooth muscle, CNS, eye, endocrine glands
Shows anticipation
Myotonia, muscle wasting, cataracts, diabetes mellitus, frontal balding, mild mental deterioration, testicular atrophy
SCAIP
Single condition amplification/internal primer sequencing
MMD or DM
Autosomal dominant
Most common form of muscular dystrophy affecting adults ~1 in 8000
Multisystem disorder-also affects heart, smooth muscle, CNS, eye, endocrine gland
Frequently appears after adolescence (slow progression)
Tendency for earlier and more severe expression from generation to generation
ANTICIPATION
Tendency for earlier and more severe expression from generation to generation
Myotonic Muscular Dystrophy
Myotonia Muscle wasting Cataracts Diabetes Mellitus Frontal balding Mild mental deterioration Testicular atrophy Targeted mutation analysis PCR using primers flanking the repeat sequence Southern blotting (larger expansions)
Facioscapulohumeral Dystrophy
Autosomally dominant
1/20,000
Principally upper body
Genetic defect on long arm of chromosome 4
Usually have normal life span (onset 10-25 years)
CK levels normal to 5 fold increase
LGMD
Range of mutations in different proteins
Autosomally dominant and recessive
Recessive more common with earlier onset (1st/2nd decade)
Weakness in upper arms/legs
4 of most common forms mutations in genes encoding sarcoglycans (alpha, beta, gamma, delta)
CK levels normal to very high
OPMD
Oculopharyngeal muscular dystrophy
Autosomal dominant rarely recessive
GCN repeat in gene encoding poly(A) binding protein PABPN1
Molecules clump in cell nuclei
Drooping eyelids, weakness in facial and pharyngeal muscles, can extend limbs
Onset 5/6th decade
Relatively rate 1/100,000
CK levels normal or midly elevated
1/1000 French-Canadiens; 1/600 Bukharan Jews, Hispanics in northern NM
CMD
Congenital muscular dystrophy Autosomal recessive MDs Present at or soon after birth About 50% due to deficiency of laminin-2 Others due to defective glycosylation of alpha-dystroglycans (impair binding to laminin) CK levels moderately high
Bethlem Myopathy
Autosomal dominant
Onset before age 5
Proximal muscle weakness (mild to progressive)
Mutation affecting Type VI collagen (chromosome 21)
Malignant hyperthermia
Rare complication of general anesthesia (1/100,000)
DMD, BMD, MMD patients particularly susceptible
Pathological release of Ca2+ in response to anesthesia (mutation in RYR gene, ryanodine receptor, protein in Ca2+ release channel)
Treated with dantrolene sodium (stabilizes membranes)